Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Entrada Therapeutics, Inc. (TRDA)
USD6.90
+0.10 (+1.47%)
US NASDAQ Healthcare Biotechnology
Address
6 Tide Street 2210
Boston, MA, US
Boston, MA, US
CEO
Dipal Doshi
Website
entradatx.com
IPO
2021-10-29
CIK 1689375 ISIN US29384C1080
Description
Entrada Therapeutics, Inc. operates as a biotechnology enterprise dedicated to pioneering endosomal escape vehicle (EEV) therapeutics, specifically engineered to tackle a range of neuromuscular ailments. The company leverages its proprietary EEV platform to cultivate a rich pipeline of therapeutic programs, integrating oligonucleotide, antibody, and enzyme-based approaches. Its foremost product candidate, ENTR-601-44, is currently undergoing preclinical assessment for its potential in addressing both Duchenne muscular dystrophy and myotonic dystrophy type 1. Furthermore, Entrada is actively developing EEV-PMO-CAG, also targeting myotonic dystrophy type 1. Incorporated in 2016, the firm was formerly known as CycloPorters, Inc., before officially changing its name to Entrada Therapeutics, Inc. in October 2017. The company maintains its corporate headquarters in Boston, Massachusetts.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD6.90
+0.10 (+1.47%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
394.1K
Beta
-0.26
Float Shares
17.75M
Free Float %
45.7%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -57.27% | -49.11% | -50.54% | -35.38% | -0.87% | -33.37% | -16.05% | -40.90% | -71.40% | -71.40% | -71.40% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (5 ratings, all time)
Buy
Price Targets & DCF
Current price
6.90
Low
20.00
+189.9%
Consensus
20.50
+197.1%
Median
20.50
+197.1%
High
21.00
+204.3%
DCF (Unlevered)
10.36
+50.2%
DCF (Levered)
6.38
-7.5%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
100% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 8 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | — | — |
| Last Quarter | 1 |
20.00
+189.9%
|
| Last Year | 3 |
18.00
+160.9%
|
| All Time | 6 |
19.17
+177.8%
|
Quality scores
Altman Z-Score
3.68
Safe zone
Piotroski F-Score
1 / 9
Weak
MOAT Score
0 / 10
No MOAT
Composite Rating
C
Overall Score
2 / 5
Medium
DCF Score
3 / 5
Medium
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
2 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
3 / 5
Medium
Operational MOAT
✗ Below peers
-
Revenue growth Biotechnology: +1.6%-87.9% Q1'26: -95.7% (vs Q1'25)
-
EPS growth Biotechnology: +29.7%-306.6% Q1'26: -126.2% (vs Q1'25)
-
FCF margin FCF growth · Biotechnology: +16.2%-584.3% Q1'26: -4,770.2% (vs Q1'25)
-
EBIT margin Biotechnology: +0.0%-561.8% Q1'26: +0.0% (vs Q1'25)
-
ROIC Biotechnology: -16.1%-232.7% Q1'26: +0.0% (vs Q1'25)
-
Share dilution Biotechnology: -3.4%+6.1% Q1'26: +1.9% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×-0.36× Q1'26: -0.29× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 6 Rev. Ana. 6 EPS Ana. |
Dec 2027 6 Rev. Ana. 6 EPS Ana. |
Dec 2028 6 Rev. Ana. 5 EPS Ana. |
Dec 2029 5 Rev. Ana. 1 EPS Ana. |
Dec 2030 3 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|
| Revenue |
—
est: 43.43M (-100.0%)
|
129.01M
est: 239.40M (-46.1%)
|
210.78M
est: 186.52M (+13.0%)
|
25.42M
est: 30.45M (-16.5%)
|
21.80M
10.85M – 36.16M
-28.4% YoY
|
31.93M
21.52M – 42.33M
+46.5% YoY
|
61.63M
60.62M – 62.64M
+93.0% YoY
|
89.67M
53.42M – 132.16M
+45.5% YoY
|
248.80M
148.21M – 366.69M
+177.5% YoY
|
| EBITDA |
-95.35M
est: 28.13M (-439.0%)
|
-321.0K
est: 59.30M (-100.5%)
|
50.78M
est: 46.20M (+9.9%)
|
-142.40M
est: 7.54M (-1,987.9%)
|
5.40M
2.69M – 8.96M
-28.4% YoY
|
7.91M
5.33M – 10.49M
+46.5% YoY
|
15.26M
15.01M – 15.51M
+93.0% YoY
|
22.21M
13.23M – 32.73M
+45.5% YoY
|
61.62M
36.71M – 90.82M
+177.5% YoY
|
| EBIT |
-97.25M
est: 27.78M (-450.0%)
|
-3.16M
est: 57.38M (-105.5%)
|
47.01M
est: 44.71M (+5.1%)
|
-142.83M
est: 7.30M (-2,056.6%)
|
5.23M
2.60M – 8.67M
-28.4% YoY
|
7.65M
5.16M – 10.15M
+46.5% YoY
|
14.77M
14.53M – 15.01M
+93.0% YoY
|
21.49M
12.80M – 31.68M
+45.5% YoY
|
59.64M
35.53M – 87.90M
+177.5% YoY
|
| Net Income |
-94.62M
est: -82.37M (-14.9%)
|
-6.69M
est: 104.44M (-106.4%)
|
65.63M
est: 43.38M (+51.3%)
|
-143.75M
est: -143.75M (+0.0%)
|
-155.38M
-175.29M – -135.47M
-8.1% YoY
|
-150.74M
-185.28M – -116.21M
+3.0% YoY
|
-194.83M
-212.16M – -50.74M
-29.2% YoY
|
-115.73M
-187.02M – -54.91M
+40.6% YoY
|
-76.80M
-124.10M – -36.44M
+33.6% YoY
|
| SGA |
30.64M
est: 29.82M (+2.8%)
|
32.29M
est: 193.80M (-83.3%)
|
38.47M
est: 150.99M (-74.5%)
|
41.05M
est: 24.65M (+66.5%)
|
17.65M
8.78M – 29.28M
-28.4% YoY
|
25.85M
17.42M – 34.27M
+46.5% YoY
|
49.89M
49.07M – 50.70M
+93.0% YoY
|
72.59M
43.24M – 106.99M
+45.5% YoY
|
201.41M
119.98M – 296.84M
+177.5% YoY
|
| EPS |
-2.79
est: -3.06 (+8.9%)
|
-0.20
est: 3.11 (-106.4%)
|
1.76
est: 1.05 (+67.1%)
|
-3.47
est: -3.61 (+3.8%)
|
-3.98
-4.24 – -3.27
-10.4% YoY
|
-3.61
-4.48 – -2.81
+9.3% YoY
|
-3.46
-5.13 – -1.23
+4.2% YoY
|
-2.80
-4.52 – -1.33
+19.1% YoY
|
-1.86
-3.00 – -0.88
+33.6% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-07 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-06 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-05 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-04 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-01 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-30 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-29 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-28 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-27 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-24 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-23 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-22 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-21 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-20 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-17 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-16 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-261.84M
OE per share TTM
-6.32
Owner's Yield
-91.37%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
78.2%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
20
Total invested
6.06M
Insider transactions (90d)
2
Beneficial owners (>5%)
27
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Baker Bros. Advisors (GP) LLC | 4.70M | 15.10% | 4.70M | — | 4.70M | — | HC, OO | Delaware | 2021-12-16 | ↗ |
| 2 | Baker Bros. Advisors LP | 4.70M | 15.10% | 4.70M | — | 4.70M | — | IA, PN | Delaware | 2021-12-16 | ↗ |
| 3 | Felix J. Baker | 4.70M | 15.10% | 4.70M | — | 4.70M | — | HC, IN | — | 2021-12-16 | ↗ |
| 4 | Julian C. Baker | 4.70M | 15.10% | 4.70M | — | 4.70M | — | HC, IN | United States | 2021-12-16 | ↗ |
| 5 | Todd Foley | 4.43M | 14.80% | 1.3K | 4.43M | 1.3K | 4.43M | IN | — | 2021-11-12 | ↗ |
| 6 | Luke Evnin | 4.43M | 14.80% | — | 4.43M | — | 4.43M | IN | — | 2021-11-12 | ↗ |
| 7 | Dr. Kush Parmar | 4.41M | 14.80% | 1.3K | 4.41M | 1.3K | 11.00 | IN | — | 2021-11-12 | ↗ |
| 8 | Andrew J. Schwab | 4.41M | 14.70% | — | 4.41M | — | 11.00 | IN | — | 2021-11-12 | ↗ |
| 9 | 5AM Partners V, LLC | 3.28M | 11.00% | — | 3.28M | — | 11.00 | OO | — | 2021-11-12 | ↗ |
| 10 | 5AM Ventures V, L.P. | 3.28M | 11.00% | — | 3.28M | — | 11.00 | PN | — | 2021-11-12 | ↗ |
| 11 | Wellington Group Holdings LLP | 3.11M | 9.98% | — | 2.92M | — | — | HC | Delaware | 2022-02-04 | ↗ |
| 12 | Wellington Investment Advisors Holdings LLP | 3.11M | 9.98% | — | 2.92M | — | — | HC | Delaware | 2022-02-04 | ↗ |
| 13 | Wellington Management Group LLP | 3.11M | 9.98% | — | 2.92M | — | — | HC | — | 2022-02-04 | ↗ |
| 14 | Wellington Management Company LLP | 2.94M | 9.41% | — | 2.87M | — | — | IA | — | 2022-02-04 | ↗ |
| 15 | Roche Finance Ltd | 2.81M | 9.00% | — | — | — | — | CO | Switzerland | 2022-02-14 | ↗ |
| 16 | Roche Holding Ltd | 2.81M | 9.00% | — | — | — | — | CO | Switzerland | 2022-02-14 | ↗ |
| 17 | Edward Hurwitz | 2.21M | 7.40% | — | 2.21M | — | 2.21M | IN | — | 2021-11-12 | ↗ |
| 18 | MPM BioVentures 2018 LLC | 2.21M | 7.40% | — | 2.21M | — | 2.21M | OO | — | 2021-11-12 | ↗ |
| 19 | 52-0556948 | 2.02M | 6.40% | 329.7K | — | — | — | IA | Maryland | 2022-02-14 | ↗ |
| 20 | Jeremy C. Green | 1.95M | 6.30% | — | 1.95M | — | 1.95M | HC, IN | — | 2022-02-14 | ↗ |
| 21 | Redmile Group, LLC | 1.95M | 6.30% | — | 1.95M | — | 1.95M | IA, OO | — | 2022-02-14 | ↗ |
| 22 | & Co., Inc. | 1.74M | 5.60% | — | 1.74M | — | 1.74M | HC | — | 2022-02-08 | ↗ |
| 23 | Sharp & Dohme Corp. | 1.74M | 5.60% | — | 1.74M | — | 1.74M | CO | — | 2022-02-08 | ↗ |
| 24 | Ventures Fund, LLC | 1.74M | 5.60% | — | 1.74M | — | 1.74M | CO | — | 2022-02-08 | ↗ |
| 25 | 5AM Opportunities I (GP), LLC | 1.13M | 3.80% | — | 1.13M | — | 11.00 | OO | — | 2021-11-12 | ↗ |
| 26 | MPM BioVentures 2014 (B), L.P. | 134.0K | 0.40% | 134.0K | — | 134.0K | — | PN | — | 2021-11-12 | ↗ |
| 27 | MPM BioVentures 2018 (B), L.P. | 109.6K | 0.40% | 109.6K | — | 109.6K | — | PN | — | 2021-11-12 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
20
-94 vs prev Q
New positions
4
Closed positions
96
Increased
13
Reduced
1
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | BAKER BROS. ADVISORS LP | 5.07M +206.9K (+4.3%) | 52.15M +23.9M (+84.8%) | 12.23% +0.464 pp | 0.31% +0.101 pp | USD16.68 -38.4% | 17 qtrs — |
| 2 | 5AM VENTURE MANAGEMENT, LLC | 4.06M -200.0K (-4.7%) | 41.70M +17.0M (+68.9%) | 9.78% -0.513 pp | 13.11% +4.068 pp | USD17.12 -40.0% | 17 qtrs — |
| 3 | BLACKROCK, INC. | 2.15M +103.2K (+5.0%) | 22.07M +10.2M (+86.2%) | 5.18% +0.234 pp | 0.00% +0.000 pp | USD15.51 -33.7% | 6 qtrs — |
| 4 | TCG CROSSOVER MANAGEMENT, LLC | 2.09M +1.5M (+257.0%) | 21.47M +18.1M (+532.8%) | 5.04% +3.622 pp | 0.71% +0.544 pp | USD12.20 -15.7% | 17 qtrs — |
| 5 | VANGUARD GROUP INC | 1.63M +28.2K (+1.8%) | 16.78M +7.5M (+80.4%) | 3.94% +0.057 pp | 0.00% +0.000 pp | USD14.70 -30.1% | 17 qtrs — |
| 6 | WELLINGTON MANAGEMENT GROUP LLP | 1.04M +90.3K (+9.5%) | 10.74M +5.2M (+94.0%) | 2.52% +0.211 pp | 0.00% +0.001 pp | USD16.24 -36.7% | 17 qtrs — |
| 7 | STEPSTONE GROUP LP | 761.3K +— (+0.0%) | 7.83M +3.4M (+77.2%) | 1.84% -0.006 pp | 4.19% +2.111 pp | USD16.89 -39.1% | 17 qtrs — |
| 8 | GEODE CAPITAL MANAGEMENT, LLC | 639.9K -5.2K (-0.8%) | 6.58M +2.8M (+75.8%) | 1.54% -0.017 pp | 0.00% +0.000 pp | USD14.47 -29.0% | 17 qtrs — |
| 9 | STATE STREET CORP | 508.8K +10.2K (+2.0%) | 5.23M +2.3M (+80.9%) | 1.23% +0.021 pp | 0.00% +0.000 pp | USD14.94 -31.2% | 17 qtrs — |
| 10 | MILLENNIUM MANAGEMENT LLC | 497.7K -338.9K (-40.5%) | 5.12M +264.0K (+5.4%) | 1.20% -0.823 pp | 0.00% +0.000 pp | USD5.99 +71.6% | 17 qtrs — |
| 11 | JACOBS LEVY EQUITY MANAGEMENT, INC | 362.8K +47.0K (+14.9%) | 3.73M +1.9M (+103.6%) | 0.88% +0.111 pp | 0.01% +0.007 pp | USD11.75 -12.5% | 7 qtrs — |
| 12 | PRICE T ROWE ASSOCIATES INC /MD/ | 327.4K -33.1K (-9.2%) | 3.37M +1.3M (+60.9%) | 0.79% -0.082 pp | 0.00% +0.000 pp | USD15.48 -33.6% | 17 qtrs — |
| 13 | ACADIAN ASSET MANAGEMENT LLC | 310.8K +12.9K (+4.3%) | 3.19M +1.5M (+85.2%) | 0.75% +0.029 pp | 0.01% +0.002 pp | USD6.72 +53.0% | 8 qtrs — |
| 14 | CITADEL ADVISORS LLC | 292.8K -43.0K (-12.8%) | 3.01M +1.1M (+54.6%) | 0.71% -0.106 pp | 0.00% +0.000 pp | USD6.43 +59.9% | 8 qtrs — |
| 15 | DIMENSIONAL FUND ADVISORS LP | 273.4K -120.9K (-30.7%) | 2.81M +522.7K (+22.9%) | 0.66% -0.294 pp | 0.00% +0.000 pp | USD12.44 -17.4% | 6 qtrs — |
| 16 | MORGAN STANLEY | 260.3K -86.5K (-24.9%) | 2.68M +664.2K (+33.0%) | 0.63% -0.211 pp | 0.00% +0.000 pp | USD7.99 +28.7% | 17 qtrs — |
| 17 | RENAISSANCE TECHNOLOGIES LLC | 252.6K -341.7K (-57.5%) | 2.60M -849.9K (-24.7%) | 0.61% -0.828 pp | 0.00% -0.001 pp | USD9.65 +6.5% | 7 qtrs — |
| 18 | ROYCE & ASSOCIATES LP | 247.1K -98.4K (-28.5%) | 2.54M +536.7K (+26.8%) | 0.60% -0.240 pp | 0.03% +0.006 pp | USD6.39 +60.9% | 3 qtrs — |
| 19 | NORTHERN TRUST CORP | 226.3K -27.3K (-10.8%) | 2.33M +855.5K (+58.2%) | 0.55% -0.068 pp | 0.00% +0.000 pp | USD15.84 -35.1% | 17 qtrs — |
| 20 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 221.3K +36.0K (+19.4%) | 2.27M +1.2M (+111.7%) | 0.53% +0.086 pp | 0.00% +0.000 pp | USD14.48 -29.0% | 17 qtrs — |
| 21 | GOLDMAN SACHS GROUP INC | 205.2K -17.2K (-7.7%) | 2.11M +819.6K (+63.6%) | 0.49% -0.043 pp | 0.00% +0.000 pp | USD9.98 +3.0% | 17 qtrs — |
| 22 | BNP PARIBAS ARBITRAGE, SNC | 181.0K +32.8K (+22.1%) | 1.86M +1.0M (+116.4%) | 0.44% +0.078 pp | 0.00% +0.000 pp | USD6.72 +53.0% | 5 qtrs — |
| 23 | QUBE RESEARCH & TECHNOLOGIES LTD | 176.0K -111.9K (-38.9%) | 1.81M +139.8K (+8.4%) | 0.42% -0.272 pp | 0.00% +0.000 pp | USD6.43 +59.9% | 4 qtrs — |
| 24 | WOODLINE PARTNERS LP | 142.1K +142.1K (+100.0%) | 1.46M +1.5M (+100.0%) | 0.34% +0.343 pp | 0.01% +0.006 pp | USD10.28 +0.0% | 1 qtrs NEW |
| 25 | ALGERT GLOBAL LLC | 128.6K -1.2K (-0.9%) | 1.32M +569.0K (+75.6%) | 0.31% -0.004 pp | 0.02% +0.008 pp | USD5.80 +77.2% | 2 qtrs — |
| 26 | TREXQUANT INVESTMENT LP | 121.3K -1.6K (-1.3%) | 1.25M +534.1K (+75.0%) | 0.29% -0.005 pp | 0.01% +0.004 pp | USD6.08 +69.1% | 6 qtrs — |
| 27 | XTX TOPCO LTD | 117.7K +24.6K (+26.4%) | 1.21M +669.8K (+124.1%) | 0.28% +0.059 pp | 0.03% +0.004 pp | USD6.74 +52.5% | 2 qtrs — |
| 28 | SPHERA FUNDS MANAGEMENT LTD. | 110.9K +110.9K (+100.0%) | 1.14M +1.1M (+100.0%) | 0.27% +0.268 pp | 0.22% +0.221 pp | USD10.28 +0.0% | 1 qtrs NEW |
| 29 | MOORE CAPITAL MANAGEMENT, LP | 105.0K +— (+0.0%) | 1.08M +470.4K (+77.2%) | 0.25% -0.001 pp | 0.02% +0.007 pp | USD17.12 -40.0% | 17 qtrs — |
| 30 | JANE STREET GROUP, LLC | 85.7K -161.9K (-65.4%) | 880.6K -555.0K (-38.7%) | 0.21% -0.392 pp | 0.00% 0.000 pp | USD5.99 +71.6% | 3 qtrs — |
| 31 | AMERIPRISE FINANCIAL INC | 84.9K +15.0K (+21.4%) | 872.7K +467.1K (+115.2%) | 0.20% +0.036 pp | 0.00% +0.000 pp | USD11.29 -8.9% | 7 qtrs — |
| 32 | BANK OF NEW YORK MELLON CORP | 79.4K -26.4K (-25.0%) | 816.0K +202.3K (+33.0%) | 0.19% -0.065 pp | 0.00% +0.000 pp | USD14.21 -27.7% | 13 qtrs — |
| 33 | AMERICAN CENTURY COMPANIES INC | 75.3K -112.0 (-0.1%) | 773.9K +336.6K (+77.0%) | 0.18% -0.001 pp | 0.00% +0.000 pp | USD13.68 -24.9% | 11 qtrs — |
| 34 | JPMORGAN CHASE & CO | 70.8K -63.1K (-47.1%) | 727.4K -49.1K (-6.3%) | 0.17% -0.153 pp | 0.00% +0.000 pp | USD6.97 +47.5% | 13 qtrs — |
| 35 | QUANTINNO CAPITAL MANAGEMENT LP | 67.7K +9.5K (+16.3%) | 696.1K +358.4K (+106.1%) | 0.16% +0.023 pp | 0.00% +0.001 pp | USD6.68 +53.9% | 3 qtrs — |
| 36 | BARCLAYS PLC | 67.1K +22.0K (+48.9%) | 690.3K -30.6K (-4.2%) | 0.16% +0.053 pp | 0.00% +0.000 pp | USD12.06 -14.8% | 16 qtrs — |
| 37 | D. E. SHAW & CO., INC. | 66.9K -4.7K (-6.5%) | 687.5K +272.5K (+65.7%) | 0.16% -0.012 pp | 0.00% +0.000 pp | USD5.80 +77.2% | 2 qtrs — |
| 38 | BANK OF AMERICA CORP /DE/ | 66.0K -60.5K (-47.8%) | 678.3K -55.1K (-7.5%) | 0.16% -0.147 pp | 0.00% +0.000 pp | USD7.84 +31.1% | 17 qtrs — |
| 39 | CANTOR FITZGERALD, L. P. | 57.0K -10.3K (-15.3%) | 586.0K -3.3M (-85.0%) | 0.14% -0.025 pp | 0.01% -0.029 pp | USD5.80 +77.2% | 2 qtrs — |
| 40 | NUVEEN, LLC | 56.4K +— (+0.0%) | 580.0K +252.7K (+77.2%) | 0.14% 0.000 pp | 0.00% +0.000 pp | USD9.04 +13.7% | 4 qtrs — |
| 41 | MANUFACTURERS LIFE INSURANCE COMPANY, THE | 56.5K -387.0 (-0.7%) | 572.3K +242.1K (+73.3%) | 0.14% -0.001 pp | 0.00% +0.000 pp | USD10.88 -5.5% | 16 qtrs — |
| 42 | LYNX1 CAPITAL MANAGEMENT LP | 51.7K +51.7K (+100.0%) | 531.4K +531.4K (+100.0%) | 0.12% +0.125 pp | 0.11% +0.108 pp | USD10.28 +0.0% | 1 qtrs NEW |
| 43 | TWO SIGMA INVESTMENTS, LP | 49.3K -43.9K (-47.1%) | 506.8K -33.7K (-6.2%) | 0.12% -0.107 pp | 0.00% 0.000 pp | USD5.80 +77.2% | 2 qtrs — |
| 44 | NAN FUNG GROUP HOLDINGS LTD | 49.1K +— (+0.0%) | 504.6K +219.9K (+77.2%) | 0.12% 0.000 pp | 0.45% -0.026 pp | USD9.39 +9.5% | 16 qtrs — |
| 45 | BREVAN HOWARD CAPITAL MANAGEMENT LP | 48.0K +48.0K (+100.0%) | 493.1K +493.1K (+100.0%) | 0.12% +0.116 pp | 0.01% +0.005 pp | USD10.28 +0.0% | 1 qtrs NEW |
| 46 | GREAT LAKES ADVISORS, LLC | 43.3K +2.2K (+5.5%) | 444.8K +206.8K (+86.9%) | 0.10% +0.005 pp | 0.00% +0.002 pp | USD6.03 +70.5% | 2 qtrs — |
| 47 | INVESCO LTD. | 41.0K +12.0K (+41.1%) | 421.8K +253.2K (+150.1%) | 0.10% +0.029 pp | 0.00% +0.000 pp | USD10.86 -5.3% | 9 qtrs — |
| 48 | BRIDGEWAY CAPITAL MANAGEMENT, LLC | 40.0K +— (+0.0%) | 411.2K +179.2K (+77.2%) | 0.10% 0.000 pp | 0.01% +0.004 pp | USD5.80 +77.2% | 2 qtrs — |
| 49 | TD ASSET MANAGEMENT INC | 37.8K +— (+0.0%) | 388.5K +169.3K (+77.2%) | 0.09% 0.000 pp | 0.00% +0.000 pp | USD16.44 -37.5% | 17 qtrs — |
| 50 | PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO | 37.5K +9.3K (+33.0%) | 385.5K +221.9K (+135.7%) | 0.09% +0.022 pp | 0.00% +0.001 pp | USD10.68 -3.7% | 7 qtrs — |
| 51 | EXODUSPOINT CAPITAL MANAGEMENT, LP | 37.4K +37.4K (+100.0%) | 384.8K +384.8K (+100.0%) | 0.09% +0.090 pp | 0.00% +0.003 pp | USD10.28 +0.0% | 7 qtrs — |
| 52 | MARTINGALE ASSET MANAGEMENT L P | 37.1K +— (+0.0%) | 380.9K +166.0K (+77.2%) | 0.09% 0.000 pp | 0.01% +0.004 pp | USD14.33 -28.3% | 8 qtrs — |
| 53 | RHUMBLINE ADVISERS | 36.2K -3.2K (-8.1%) | 372.4K +143.7K (+62.8%) | 0.09% -0.008 pp | 0.00% +0.000 pp | USD14.30 -28.1% | 11 qtrs — |
| 54 | WELLS FARGO & COMPANY/MN | 32.2K +10.5K (+48.8%) | 330.6K +205.3K (+163.7%) | 0.08% +0.025 pp | 0.00% +0.000 pp | USD11.77 -12.7% | 17 qtrs — |
| 55 | LOS ANGELES CAPITAL MANAGEMENT LLC | 46.0K -6.1K (-11.8%) | 317.1K +15.0K (+5.0%) | 0.11% -0.015 pp | 0.00% +0.000 pp | USD11.53 -10.8% | 6 qtrs — |
| 56 | AQR CAPITAL MANAGEMENT LLC | 26.3K +12.3K (+87.6%) | 269.9K +188.7K (+232.6%) | 0.06% +0.030 pp | 0.00% +0.000 pp | USD12.84 -19.9% | 6 qtrs — |
| 57 | CANADA PENSION PLAN INVESTMENT BOARD | 25.6K +25.6K (+100.0%) | 263.2K +263.2K (+100.0%) | 0.06% +0.062 pp | 0.00% +0.000 pp | USD10.28 +0.0% | 1 qtrs NEW |
| 58 | DYNAMIC TECHNOLOGY LAB PRIVATE LTD | 25.3K +25.3K (+100.0%) | 260.0K +260.0K (+100.0%) | 0.06% +0.061 pp | 0.06% +0.059 pp | USD10.28 +0.0% | 3 qtrs — |
| 59 | ALLIANCEBERNSTEIN L.P. | 24.3K +— (+0.0%) | 250.0K +109.0K (+77.2%) | 0.06% 0.000 pp | 0.00% +0.000 pp | USD10.82 -5.0% | 7 qtrs — |
| 60 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 22.2K +8.5K (+62.0%) | 228.2K +148.8K (+187.2%) | 0.05% +0.020 pp | 0.00% +0.000 pp | USD8.08 +27.2% | 6 qtrs — |
| 61 | CREATIVE PLANNING | 22.1K +22.1K (+100.0%) | 227.0K +227.0K (+100.0%) | 0.05% +0.053 pp | 0.00% +0.000 pp | USD10.28 +0.0% | 1 qtrs NEW |
| 62 | POINT72 ASSET MANAGEMENT, L.P. | 21.9K +21.9K (+100.0%) | 224.8K +224.8K (+100.0%) | 0.05% +0.053 pp | 0.00% +0.000 pp | USD10.28 +0.0% | 1 qtrs NEW |
| 63 | HSBC HOLDINGS PLC | 20.8K +194.0 (+0.9%) | 216.2K +99.0K (+84.5%) | 0.05% +0.000 pp | 0.00% +0.000 pp | USD5.84 +76.0% | 2 qtrs — |
| 64 | DEUTSCHE BANK AG\ | 20.8K -187.0 (-0.9%) | 214.0K +92.2K (+75.7%) | 0.05% -0.001 pp | 0.00% +0.000 pp | USD13.40 -23.3% | 11 qtrs — |
| 65 | MARSHALL WACE, LLP | 20.7K +20.7K (+100.0%) | 212.4K +212.4K (+100.0%) | 0.05% +0.050 pp | 0.00% +0.000 pp | USD10.28 +0.0% | 1 qtrs NEW |
| 66 | QUADRATURE CAPITAL LTD | 20.3K +2.4K (+13.5%) | 208.9K +105.4K (+101.9%) | 0.05% +0.006 pp | 0.00% +0.001 pp | USD6.33 +62.4% | 2 qtrs — |
| 67 | UBS GROUP AG | 19.0K +126.0 (+0.7%) | 195.7K +86.0K (+78.4%) | 0.05% +0.000 pp | 0.00% +0.000 pp | USD16.22 -36.6% | 17 qtrs — |
| 68 | METLIFE INVESTMENT MANAGEMENT, LLC | 17.8K +10.6K (+148.6%) | 183.0K +141.5K (+340.7%) | 0.04% +0.026 pp | 0.00% +0.001 pp | USD12.27 -16.2% | 11 qtrs — |
| 69 | ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC | 17.5K +1.6K (+9.8%) | 175.8K +83.4K (+90.2%) | 0.04% +0.004 pp | 0.00% +0.000 pp | USD12.24 -16.0% | 10 qtrs — |
| 70 | FMR LLC | 16.8K -15.1K (-47.3%) | 172.9K -12.4K (-6.7%) | 0.04% -0.037 pp | 0.00% +0.000 pp | USD14.14 -27.3% | 17 qtrs — |
| 71 | QUEST PARTNERS LLC | 15.6K +9.2K (+141.4%) | 160.7K +123.1K (+327.8%) | 0.04% +0.022 pp | 0.01% +0.007 pp | USD9.44 +8.9% | 5 qtrs — |
| 72 | BALYASNY ASSET MANAGEMENT L.P. | 14.0K +14.0K (+100.0%) | 144.1K +144.1K (+100.0%) | 0.03% +0.034 pp | 0.00% +0.000 pp | USD10.28 +0.0% | 1 qtrs NEW |
| 73 | WALLEYE CAPITAL LLC | 13.5K -83.1K (-86.0%) | 139.1K -421.6K (-75.2%) | 0.03% -0.201 pp | 0.00% -0.002 pp | USD5.97 +72.2% | 3 qtrs — |
| 74 | MAGNETAR FINANCIAL LLC | 13.4K +13.4K (+100.0%) | 137.5K +137.5K (+100.0%) | 0.03% +0.032 pp | 0.00% +0.001 pp | USD10.28 +0.0% | 1 qtrs NEW |
| 75 | MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 13.2K +140.0 (+1.1%) | 136.2K +60.2K (+79.1%) | 0.03% +0.000 pp | 0.00% +0.000 pp | USD14.13 -27.2% | 7 qtrs — |
| 76 | INTECH INVESTMENT MANAGEMENT LLC | 11.9K -1.9K (-13.8%) | 122.6K +42.3K (+52.7%) | 0.03% -0.005 pp | 0.00% +0.000 pp | USD8.73 +17.8% | 4 qtrs — |
| 77 | INSCRIPTION CAPITAL, LLC | 11.8K +— (+0.0%) | 121.7K +53.0K (+77.2%) | 0.03% 0.000 pp | 0.01% +0.005 pp | USD5.80 +77.2% | 2 qtrs — |
| 78 | RUSSELL INVESTMENTS GROUP, LTD. | 11.6K +2.8K (+31.4%) | 118.9K +67.9K (+132.8%) | 0.03% +0.007 pp | 0.00% +0.000 pp | USD11.70 -12.1% | 11 qtrs — |
| 79 | IHT WEALTH MANAGEMENT, LLC | 11.1K +— (+0.0%) | 114.1K +49.7K (+77.2%) | 0.03% 0.000 pp | 0.00% +0.001 pp | USD6.69 +53.7% | 3 qtrs — |
| 80 | AXQ CAPITAL, LP | 10.7K -920.0 (-8.0%) | 109.5K +42.4K (+63.1%) | 0.03% -0.002 pp | 0.02% -0.001 pp | USD5.80 +77.2% | 2 qtrs — |
| 81 | POLICE & FIREMEN'S RETIREMENT SYSTEM OF NEW JERSEY | 9.5K +— (+0.0%) | 97.4K +42.4K (+77.2%) | 0.02% 0.000 pp | 0.00% +0.000 pp | USD11.77 -12.7% | 5 qtrs — |
| 82 | NEW YORK STATE COMMON RETIREMENT FUND | 8.9K +— (+0.0%) | 91.3K +39.8K (+77.2%) | 0.02% 0.000 pp | 0.00% +0.000 pp | USD15.16 -32.2% | 11 qtrs — |
| 83 | CHINA UNIVERSAL ASSET MANAGEMENT CO., LTD. | 6.2K -439.0 (-6.6%) | 64.0K +25.4K (+65.6%) | 0.02% -0.001 pp | 0.00% +0.002 pp | USD17.18 -40.2% | 5 qtrs — |
| 84 | CITIGROUP INC | 4.1K +2.1K (+101.3%) | 42.4K +30.5K (+256.7%) | 0.01% +0.005 pp | 0.00% +0.000 pp | USD12.88 -20.2% | 17 qtrs — |
| 85 | VERSANT CAPITAL MANAGEMENT, INC | 4.0K +27.0 (+0.7%) | 41.6K +18.3K (+78.4%) | 0.01% +0.000 pp | 0.01% +0.002 pp | USD6.16 +66.9% | 3 qtrs — |
| 86 | LEGAL & GENERAL GROUP PLC | 2.6K +— (+0.0%) | 26.3K +11.5K (+77.2%) | 0.01% +0.000 pp | 0.00% +0.000 pp | USD15.22 -32.5% | 13 qtrs — |
| 87 | AMERITAS INVESTMENT PARTNERS, INC. | 2.4K +— (+0.0%) | 24.8K +10.8K (+77.2%) | 0.01% +0.000 pp | 0.00% +0.000 pp | USD15.37 -33.1% | 11 qtrs — |
| 88 | CWM, LLC | 2.1K +921.0 (+77.2%) | 22.0K +15.0K (+214.3%) | 0.01% +0.002 pp | 0.00% +0.000 pp | USD8.69 +18.3% | 6 qtrs — |
| 89 | TOWER RESEARCH CAPITAL LLC (TRC) | 1.9K -5.4K (-73.7%) | 19.9K -22.8K (-53.3%) | 0.00% -0.013 pp | 0.00% -0.001 pp | USD7.67 +34.0% | 17 qtrs — |
| 90 | MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. | 1.9K +386.0 (+26.2%) | 19.1K +10.6K (+123.7%) | 0.00% +0.001 pp | 0.00% +0.000 pp | USD14.56 -29.4% | 5 qtrs — |
| 91 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 1.8K -37.0 (-2.1%) | 18.0K +7.6K (+73.6%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD14.26 -27.9% | 13 qtrs — |
| 92 | STERLING CAPITAL MANAGEMENT LLC | 1.6K -301.0 (-15.5%) | 16.9K +5.6K (+49.8%) | 0.00% -0.001 pp | 0.00% +0.000 pp | USD8.42 +22.1% | 6 qtrs — |
| 93 | PNC FINANCIAL SERVICES GROUP, INC. | 1.1K -16.0 (-1.4%) | 11.7K +5.0K (+74.8%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD5.80 +77.2% | 2 qtrs — |
| 94 | ROYAL BANK OF CANADA | 987.00 -41.2K (-97.7%) | 11.0K -234.0K (-95.5%) | 0.00% -0.100 pp | 0.00% +0.000 pp | USD7.88 +30.5% | 11 qtrs — |
| 95 | SRS CAPITAL ADVISORS, INC. | 918.00 -361.0 (-28.2%) | 9.4K +2.0K (+27.2%) | 0.00% -0.001 pp | 0.00% +0.000 pp | USD6.13 +67.7% | 3 qtrs — |
| 96 | AMALGAMATED BANK | 894.00 +42.0 (+4.9%) | 9.0K +4.0K (+80.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD14.02 -26.7% | 11 qtrs — |
| 97 | GF FUND MANAGEMENT CO. LTD. | 751.00 -56.0 (-6.9%) | 7.7K +3.0K (+64.9%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD15.80 -34.9% | 5 qtrs — |
| 98 | ZURCHER KANTONALBANK (ZURICH CANTONALBANK) | 432.00 +— (+0.0%) | 4.4K +1.9K (+77.2%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD9.04 +13.7% | 4 qtrs — |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 61 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Harbor Human Capital Factor US Small Cap ETF HAPS | 0.13% | 230.9K | 0.61% |
| 2 | iShares Micro-Cap ETF IWC | 0.05% | 684.1K | 0.60% |
| 3 | iShares Nasdaq US Biotechnology UCITS ETF BTEE.L | 0.02% | 14.2K | 0.35% |
| 4 | iShares Nasdaq US Biotechnology UCITS ETF BTEC.L | 0.02% | 212.8K | 0.35% |
| 5 | Invesco NASDAQ Biotech UCITS ETF SBIO.L | 0.02% | 85.7K | 0.40% |
| 6 | Invesco Nasdaq Biotechnology ETF IBBQ | 0.02% | 13.8K | 0.19% |
| 7 | Avantis U.S. Small Cap Equity ETF AVSC | 0.02% | 469.1K | 0.25% |
| 8 | Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF GSSC | 0.01% | 137.4K | 0.20% |
| 9 | Vanguard Russell 2000 Value ETF VTWV | 0.01% | 169.0K | 0.06% |
| 10 | iShares Russell 2000 Value ETF IWN | 0.01% | 1.85M | 0.24% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.25
Bearish
Ratio by volume
0.26
Bearish
Buys
1
Sells
4
Shares acquired
15.0K
Shares disposed
58.4K
Cash buys
—
Cash sales
3.00
Net activity
-43,407
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-04 | Sethuraman Natarajan | Officer | S-Sale | D | Common Stock | 25,907 | 15.39 | 398.8K | 216,317 | D | ↗ |
| 2026-05-04 | Dowden Nathan J | Officer | M-Exempt | A | Common Stock | 15,000 | 1.74 | 26.1K | 213,588 | D | ↗ |
| 2026-04-01 | WENTWORTH KORY JAMES | Officer | S-Sale | D | Common Stock | 2,500 | 12.95 | 32.4K | 119,010 | D | ↗ |
| 2026-03-10 | WENTWORTH KORY JAMES | Officer | S-Sale | D | Common Stock | 11,388 | 13.02 | 148.2K | 121,510 | D | ↗ |
| 2026-03-10 | Dowden Nathan J | Officer | S-Sale | D | Common Stock | 11,894 | 13.05 | 155.2K | 198,588 | D | ↗ |
| 2026-03-09 | WENTWORTH KORY JAMES | Officer | S-Sale | D | Common Stock | 5,089 | 13.00 | 66.2K | 132,898 | D | ↗ |
| 2026-03-09 | Dowden Nathan J | Officer | S-Sale | D | Common Stock | 3,116 | 13.02 | 40.6K | 210,482 | D | ↗ |
| 2026-03-04 | WENTWORTH KORY JAMES | Officer | S-Sale | D | Common Stock | 7,988 | 12.25 | 97.9K | 137,987 | D | ↗ |
| 2026-03-03 | WENTWORTH KORY JAMES | Officer | F-InKind | D | Common Stock | 5,712 | 11.76 | 67.2K | 145,975 | D | ↗ |
| 2026-03-03 | Sethuraman Natarajan | Officer | F-InKind | D | Common Stock | 7,577 | 11.76 | 89.1K | 242,224 | D | ↗ |
| 2026-03-03 | Dowden Nathan J | Officer | F-InKind | D | Common Stock | 14,038 | 11.76 | 165.0K | 213,598 | D | ↗ |
| 2026-03-03 | Doshi Dipal | Director / Officer | F-InKind | D | Common Stock | 19,181 | 11.76 | 225.5K | 526,014 | D | ↗ |
| 2026-03-02 | WENTWORTH KORY JAMES | Officer | F-InKind | D | Common Stock | 2,939 | 11.66 | 34.3K | 151,687 | D | ↗ |
| 2026-03-02 | Sethuraman Natarajan | Officer | F-InKind | D | Common Stock | 3,898 | 11.66 | 45.4K | 249,801 | D | ↗ |
| 2026-03-02 | Dowden Nathan J | Officer | F-InKind | D | Common Stock | 7,223 | 11.66 | 84.2K | 227,636 | D | ↗ |
| 2026-03-02 | Doshi Dipal | Director / Officer | F-InKind | D | Common Stock | 9,869 | 11.66 | 115.1K | 545,195 | D | ↗ |
| 2026-03-01 | WENTWORTH KORY JAMES | Officer | A-Award | A | Stock Option (Right to Buy) | 66,600 | 11.93 | 794.5K | 66,600 | D | ↗ |
| 2026-03-01 | Sethuraman Natarajan | Officer | A-Award | A | Stock Option (Right to Buy) | 83,200 | 11.93 | 992.6K | 83,200 | D | ↗ |
| 2026-03-01 | Dowden Nathan J | Officer | A-Award | A | Stock Option (Right to Buy) | 83,200 | 11.93 | 992.6K | 83,200 | D | ↗ |
| 2026-03-01 | Doshi Dipal | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 208,000 | 11.93 | 2.48M | 208,000 | D | ↗ |
| 2025-11-21 | WENTWORTH KORY JAMES | Officer | S-Sale | D | Common Stock | 8,910 | 9.98 | 88.9K | 110,026 | D | ↗ |
| 2025-11-20 | BAKER BROS. ADVISORS LP | 10% Owner | P-Purchase | A | Common Stock | 1,186 | 9.07 | 10.8K | 381,338 | I | ↗ |
| 2025-11-14 | PARMAR KUSH | Director / 10% Owner | S-Sale | D | Common Stock | 200,000 | 8.80 | 1.76M | 2,963,066 | I | ↗ |
| 2025-11-14 | 5AM Ventures V, L.P. | 10% Owner | S-Sale | D | Common Stock | 200,000 | 8.80 | 1.76M | 2,963,066 | D | ↗ |
| 2025-11-12 | BAKER BROS. ADVISORS LP | 10% Owner | P-Purchase | A | Common Stock | 1,040 | 7.95 | 8.3K | 378,939 | I | ↗ |
| 2025-11-11 | BAKER BROS. ADVISORS LP | 10% Owner | P-Purchase | A | Common Stock | 2,795 | 7.54 | 21.1K | 370,578 | I | ↗ |
| 2025-11-10 | BAKER BROS. ADVISORS LP | 10% Owner | P-Purchase | A | Common Stock | 25,364 | 7.21 | 183.0K | 4,527,022 | I | ↗ |
| 2025-09-02 | WENTWORTH KORY JAMES | Officer | F-InKind | D | Common Stock | 1,734 | 5.43 | 9.4K | 118,936 | D | ↗ |
| 2025-09-02 | Sethuraman Natarajan | Officer | F-InKind | D | Common Stock | 1,760 | 5.43 | 9.6K | 197,899 | D | ↗ |
| 2025-09-02 | Dowden Nathan J | Officer | F-InKind | D | Common Stock | 1,746 | 5.43 | 9.5K | 179,059 | D | ↗ |
| 2025-09-02 | Doshi Dipal | Director / Officer | F-InKind | D | Common Stock | 8,723 | 5.43 | 47.4K | 415,664 | D | ↗ |
| 2025-07-09 | PARMAR KUSH | Director / 10% Owner | S-Sale | D | Common Stock | 20,065 | 7.50 | 150.5K | 3,163,066 | I | ↗ |
| 2025-07-09 | 5AM Ventures V, L.P. | 10% Owner | S-Sale | D | Common Stock | 20,065 | 7.50 | 150.5K | 3,163,066 | D | ↗ |
| 2025-07-01 | PARMAR KUSH | Director / 10% Owner | S-Sale | D | Common Stock | 18,578 | 7.12 | 132.3K | 3,183,131 | I | ↗ |
| 2025-07-01 | 5AM Ventures V, L.P. | 10% Owner | S-Sale | D | Common Stock | 6,422 | 7.12 | 45.7K | 1,100,248 | I | ↗ |
| 2025-06-30 | PARMAR KUSH | Director / 10% Owner | S-Sale | D | Common Stock | 6,422 | 6.81 | 43.8K | 1,106,670 | I | ↗ |
| 2025-06-30 | 5AM Ventures V, L.P. | 10% Owner | S-Sale | D | Common Stock | 6,422 | 6.81 | 43.8K | 1,106,670 | I | ↗ |
| 2025-06-27 | PARMAR KUSH | Director / 10% Owner | S-Sale | D | Common Stock | 19,265 | 6.91 | 133.1K | 1,113,092 | I | ↗ |
| 2025-06-27 | 5AM Ventures V, L.P. | 10% Owner | S-Sale | D | Common Stock | 19,265 | 6.91 | 133.1K | 1,113,092 | I | ↗ |
| 2025-06-11 | Zeiher Bernhardt G | Director | A-Award | A | Stock Option (Right to Buy) | 19,000 | 7.90 | 150.1K | 19,000 | D | ↗ |
| 2025-06-11 | Thistle Mary | Director | A-Award | A | Stock Option (Right to Buy) | 19,000 | 7.90 | 150.1K | 19,000 | D | ↗ |
| 2025-06-11 | PARMAR KUSH | Director / 10% Owner | A-Award | A | Stock Option (Right to Buy) | 19,000 | 7.90 | 150.1K | 19,000 | D | ↗ |
| 2025-06-11 | KIM PETER S | Director | A-Award | A | Stock Option (Right to Buy) | 19,000 | 7.90 | 150.1K | 19,000 | D | ↗ |
| 2025-06-11 | Chapman Gina | Director | A-Award | A | Stock Option (Right to Buy) | 19,000 | 7.90 | 150.1K | 19,000 | D | ↗ |
| 2025-06-01 | Radhakrishnan Maha | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2025-04-03 | WENTWORTH KORY JAMES | Officer | M-Exempt | D | Stock Option (Right to Buy) | 11,134 | 2.10 | 23.4K | 20,023 | D | ↗ |
| 2025-03-17 | WENTWORTH KORY JAMES | Officer | S-Sale | D | Common Stock | 1,784 | 10.67 | 19.0K | 109,536 | D | ↗ |
| 2025-03-03 | WENTWORTH KORY JAMES | Officer | F-InKind | D | Common Stock | 4,929 | 11.68 | 57.6K | 111,320 | D | ↗ |
| 2025-03-03 | Sethuraman Natarajan | Officer | F-InKind | D | Common Stock | 6,138 | 11.68 | 71.7K | 199,659 | D | ↗ |
| 2025-03-03 | Dowden Nathan J | Officer | F-InKind | D | Common Stock | 5,144 | 11.68 | 60.1K | 180,805 | D | ↗ |
| 2025-03-03 | Doshi Dipal | Director / Officer | F-InKind | D | Common Stock | 17,566 | 11.68 | 205.1K | 424,387 | D | ↗ |
| 2025-03-01 | WENTWORTH KORY JAMES | Officer | A-Award | A | Common Stock | 42,400 | 0.00 | — | 116,249 | D | ↗ |
| 2025-03-01 | Sethuraman Natarajan | Officer | A-Award | A | Common Stock | 60,800 | 0.00 | — | 205,797 | D | ↗ |
| 2025-03-01 | Dowden Nathan J | Officer | A-Award | A | Common Stock | 60,800 | 0.00 | — | 185,949 | D | ↗ |
| 2025-03-01 | Doshi Dipal | Director / Officer | A-Award | A | Common Stock | 116,200 | 0.00 | — | 441,953 | D | ↗ |
| 2024-12-11 | MPM BioVentures 2014, L.P. | 10% Owner | S-Sale | D | Common Stock | 21,787 | 20.23 | 440.8K | 4,381,062 | I | ↗ |
| 2024-12-11 | MPM BIOVENTURES 2018, L.P. | 10% Owner | S-Sale | D | Common Stock | 21,787 | 20.23 | 440.8K | 4,381,062 | I | ↗ |
| 2024-12-10 | MPM BioVentures 2014, L.P. | 10% Owner | S-Sale | D | Common Stock | 22,935 | 20.77 | 476.4K | 4,402,849 | I | ↗ |
| 2024-12-10 | MPM BIOVENTURES 2018, L.P. | 10% Owner | S-Sale | D | Common Stock | 22,935 | 20.77 | 476.4K | 4,402,849 | I | ↗ |
| 2024-12-03 | Sethuraman Natarajan | Officer | S-Sale | D | Common Stock | 11,703 | 20.15 | 235.8K | 144,997 | D | ↗ |
| 2024-12-02 | WENTWORTH KORY JAMES | Officer | S-Sale | D | Common Stock | 5,000 | 20.00 | 100.0K | 73,849 | D | ↗ |
| 2024-12-02 | Sethuraman Natarajan | Officer | S-Sale | D | Common Stock | 4,088 | 20.26 | 82.8K | 156,700 | D | ↗ |
| 2024-11-29 | WENTWORTH KORY JAMES | Officer | M-Exempt | A | Common Stock | 1,000 | 2.10 | 2.1K | 74,849 | D | ↗ |
| 2024-11-29 | Sethuraman Natarajan | Officer | S-Sale | D | Common Stock | 100 | 20.00 | 2.0K | 160,788 | D | ↗ |
| 2024-11-13 | Sethuraman Natarajan | Officer | S-Sale | D | Common Stock | 2,700 | 20.04 | 54.1K | 160,888 | D | ↗ |
| 2024-11-11 | WENTWORTH KORY JAMES | Officer | S-Sale | D | Common Stock | 8,637 | 19.98 | 172.6K | 73,849 | D | ↗ |
| 2024-11-11 | Sethuraman Natarajan | Officer | S-Sale | D | Common Stock | 1,409 | 20.01 | 28.2K | 163,588 | D | ↗ |
| 2024-11-06 | Sethuraman Natarajan | Officer | S-Sale | D | Common Stock | 9,554 | 18.71 | 178.8K | 167,742 | D | ↗ |
| 2024-11-05 | Sethuraman Natarajan | Officer | S-Sale | D | Common Stock | 5,171 | 18.18 | 94.0K | 177,296 | D | ↗ |
| 2024-11-04 | Sethuraman Natarajan | Officer | S-Sale | D | Common Stock | 749 | 18.02 | 13.5K | 182,467 | D | ↗ |
| 2024-10-16 | Sethuraman Natarajan | Officer | S-Sale | D | Common Stock | 600 | 18.00 | 10.8K | 183,216 | D | ↗ |
| 2024-09-26 | Dowden Nathan J | Officer | S-Sale | D | Common Stock | 847 | 16.00 | 13.6K | 125,149 | D | ↗ |
| 2024-09-09 | WENTWORTH KORY JAMES | Officer | S-Sale | D | Common Stock | 3,195 | 14.97 | 47.8K | 76,486 | — | ↗ |
| 2024-09-09 | Sethuraman Natarajan | Officer | S-Sale | D | Common Stock | 2,642 | 15.09 | 39.9K | 183,816 | — | ↗ |
| 2024-09-09 | Dowden Nathan J | Officer | S-Sale | D | Common Stock | 1,904 | 15.07 | 28.7K | 125,996 | — | ↗ |
| 2024-09-06 | Sethuraman Natarajan | Officer | S-Sale | D | Common Stock | 600 | 15.24 | 9.1K | 186,458 | — | ↗ |
| 2024-09-06 | Dowden Nathan J | Officer | S-Sale | D | Common Stock | 399 | 15.19 | 6.1K | 127,900 | — | ↗ |
| 2024-09-05 | WENTWORTH KORY JAMES | Officer | F-InKind | D | Common Stock | 165 | 15.13 | 2.5K | 79,681 | — | ↗ |
| 2024-09-05 | Sethuraman Natarajan | Officer | F-InKind | D | Common Stock | 167 | 15.13 | 2.5K | 187,058 | — | ↗ |
| 2024-09-05 | Dowden Nathan J | Officer | F-InKind | D | Common Stock | 171 | 15.13 | 2.6K | 128,299 | — | ↗ |
| 2024-09-05 | Doshi Dipal | Director / Officer | F-InKind | D | Common Stock | 826 | 15.13 | 12.5K | 325,753 | — | ↗ |
| 2024-09-04 | WENTWORTH KORY JAMES | Officer | F-InKind | D | Common Stock | 941 | 15.42 | 14.5K | 79,846 | — | ↗ |
| 2024-09-04 | Sethuraman Natarajan | Officer | F-InKind | D | Common Stock | 955 | 15.42 | 14.7K | 187,225 | — | ↗ |
| 2024-09-04 | Dowden Nathan J | Officer | F-InKind | D | Common Stock | 983 | 15.42 | 15.2K | 128,470 | — | ↗ |
| 2024-09-04 | Doshi Dipal | Director / Officer | F-InKind | D | Common Stock | 4,744 | 15.42 | 73.2K | 326,579 | — | ↗ |
| 2024-09-03 | WENTWORTH KORY JAMES | Officer | F-InKind | D | Common Stock | 14 | 17.70 | 247.83 | 80,787 | — | ↗ |
| 2024-09-03 | Sethuraman Natarajan | Officer | F-InKind | D | Common Stock | 151 | 16.93 | 2.6K | 188,194 | — | ↗ |
| 2024-09-03 | Dowden Nathan J | Officer | F-InKind | D | Common Stock | 15 | 17.70 | 265.53 | 129,453 | — | ↗ |
| 2024-09-03 | Doshi Dipal | Director / Officer | F-InKind | D | Common Stock | 72 | 17.70 | 1.3K | 331,323 | — | ↗ |
| 2024-08-16 | Dowden Nathan J | Officer | M-Exempt | A | Common Stock | 20,000 | 1.74 | 34.8K | 157,204 | — | ↗ |
| 2024-07-15 | Sethuraman Natarajan | Officer | S-Sale | D | Common Stock | 638 | 18.00 | 11.5K | 188,814 | — | ↗ |
| 2024-07-15 | Doshi Dipal | Director / Officer | S-Sale | D | Common Stock | 1,600 | 17.81 | 28.5K | 334,475 | — | ↗ |
| 2024-07-12 | Sethuraman Natarajan | Officer | S-Sale | D | Common Stock | 600 | 18.00 | 10.8K | 189,452 | — | ↗ |
| 2024-07-12 | Doshi Dipal | Director / Officer | S-Sale | D | Common Stock | 300 | 18.00 | 5.4K | 336,075 | — | ↗ |
| 2024-07-08 | WENTWORTH KORY JAMES | Officer | S-Sale | D | Common Stock | 1,758 | 14.95 | 26.3K | 81,412 | — | ↗ |
| 2024-06-25 | BAKER BROS. ADVISORS LP | 10% Owner | P-Purchase | A | Warrants to purchase Common Stock | 3,081,303 | 0.00 | 308.13 | 3,081,303 | — | ↗ |
| 2024-06-13 | Zeiher Bernhardt G | Director | A-Award | A | Stock Option (Right to Buy) | 16,000 | 16.45 | 263.2K | 16,000 | — | ↗ |
| 2024-06-13 | Thistle Mary | Director | A-Award | A | Stock Option (Right to Buy) | 16,000 | 16.45 | 263.2K | 16,000 | — | ↗ |
| 2024-06-13 | PARMAR KUSH | Director / 10% Owner | A-Award | A | Stock Option (Right to Buy) | 16,000 | 16.45 | 263.2K | 16,000 | — | ↗ |
| 2024-06-13 | KIM PETER S | Director | A-Award | A | Stock Option (Right to Buy) | 16,000 | 16.45 | 263.2K | 16,000 | — | ↗ |
| 2024-06-13 | Doshi Dipal | Director / Officer | S-Sale | D | Common Stock | 1,000 | 16.17 | 16.2K | 336,375 | — | ↗ |
| 2024-06-13 | Chapman Gina | Director | A-Award | A | Stock Option (Right to Buy) | 16,000 | 16.45 | 263.2K | 16,000 | — | ↗ |
| 2024-06-03 | KIM PETER S | Director | M-Exempt | D | Stock Option (Right to Buy) | 11,918 | 6.06 | 72.2K | 0 | — | ↗ |
| 2024-05-20 | Sethuraman Natarajan | Officer | S-Sale | D | Common Stock | 9,675 | 15.19 | 146.9K | 190,052 | — | ↗ |
| 2024-05-17 | Sethuraman Natarajan | Officer | S-Sale | D | Common Stock | 8,305 | 15.14 | 125.8K | 199,727 | — | ↗ |
| 2024-05-17 | Doshi Dipal | Director / Officer | S-Sale | D | Common Stock | 1,200 | 15.11 | 18.1K | 337,375 | — | ↗ |
| 2024-05-16 | Sethuraman Natarajan | Officer | S-Sale | D | Common Stock | 1,000 | 15.00 | 15.0K | 208,032 | — | ↗ |
| 2024-05-16 | Doshi Dipal | Director / Officer | S-Sale | D | Common Stock | 1,800 | 15.00 | 27.0K | 338,575 | — | ↗ |
| 2024-05-14 | KIM PETER S | Director | P-Purchase | A | Common Stock | 25,000 | 14.59 | 364.7K | 117,412 | D | ↗ |
| 2024-05-13 | KIM PETER S | Director | P-Purchase | A | Common Stock | 25,000 | 14.68 | 367.0K | 92,412 | D | ↗ |
| 2024-05-09 | KIM PETER S | Director | P-Purchase | A | Common Stock | 2,200 | 14.25 | 31.3K | 67,412 | — | ↗ |
| 2024-05-08 | KIM PETER S | Director | P-Purchase | A | Common Stock | 2,276 | 14.04 | 32.0K | 65,212 | — | ↗ |
| 2024-04-08 | KIM PETER S | Director | P-Purchase | A | Common Stock | 2,600 | 13.57 | 35.3K | 62,936 | — | ↗ |
| 2024-03-28 | KIM PETER S | Director | P-Purchase | A | Common Stock | 1,512 | 13.75 | 20.8K | 60,336 | — | ↗ |
| 2024-03-26 | KIM PETER S | Director | P-Purchase | A | Common Stock | 2,750 | 13.64 | 37.5K | 58,824 | — | ↗ |
| 2024-03-25 | KIM PETER S | Director | P-Purchase | A | Common Stock | 3,180 | 13.36 | 42.5K | 56,074 | — | ↗ |
| 2024-03-22 | KIM PETER S | Director | P-Purchase | A | Common Stock | 3,118 | 13.76 | 42.9K | 52,894 | — | ↗ |
| 2024-03-21 | KIM PETER S | Director | P-Purchase | A | Common Stock | 704 | 13.24 | 9.3K | 49,776 | — | ↗ |
| 2024-03-20 | KIM PETER S | Director | P-Purchase | A | Common Stock | 1,128 | 12.66 | 14.3K | 49,072 | — | ↗ |
| 2024-03-19 | KIM PETER S | Director | P-Purchase | A | Common Stock | 900 | 12.66 | 11.4K | 47,944 | — | ↗ |
| 2024-03-15 | WENTWORTH KORY JAMES | Officer | M-Exempt | D | Stock Option (Right to Buy) | 9,000 | 2.10 | 18.9K | 43,157 | — | ↗ |
| 2024-03-06 | WENTWORTH KORY JAMES | Officer | S-Sale | D | Common Stock | 4,086 | 12.31 | 50.3K | 74,170 | — | ↗ |
| 2024-03-06 | Dowden Nathan J | Officer | S-Sale | D | Common Stock | 1,826 | 12.32 | 22.5K | 137,204 | — | ↗ |
| 2024-03-05 | WENTWORTH KORY JAMES | Officer | F-InKind | D | Common Stock | 1,471 | 12.28 | 18.1K | 78,256 | — | ↗ |
| 2024-03-05 | Sethuraman Natarajan | Officer | F-InKind | D | Common Stock | 1,505 | 12.28 | 18.5K | 209,032 | — | ↗ |
| 2024-03-05 | Dowden Nathan J | Officer | F-InKind | D | Common Stock | 1,486 | 12.28 | 18.2K | 139,030 | — | ↗ |
| 2024-03-05 | Doshi Dipal | Director / Officer | F-InKind | D | Common Stock | 5,049 | 12.28 | 62.0K | 340,375 | — | ↗ |
| 2024-03-04 | WENTWORTH KORY JAMES | Officer | F-InKind | D | Common Stock | 405 | 13.37 | 5.4K | 79,727 | — | ↗ |
| 2024-03-04 | Sethuraman Natarajan | Officer | F-InKind | D | Common Stock | 414 | 13.37 | 5.5K | 210,537 | — | ↗ |
| 2024-03-04 | Dowden Nathan J | Officer | F-InKind | D | Common Stock | 409 | 13.37 | 5.5K | 140,516 | — | ↗ |
| 2024-03-04 | Doshi Dipal | Director / Officer | F-InKind | D | Common Stock | 1,391 | 13.37 | 18.6K | 345,424 | — | ↗ |
| 2024-03-01 | WENTWORTH KORY JAMES | Officer | A-Award | A | Common Stock | 30,900 | 0.00 | — | 80,471 | — | ↗ |
| 2024-03-01 | Sethuraman Natarajan | Officer | A-Award | A | Common Stock | 44,100 | 0.00 | — | 211,298 | — | ↗ |
| 2024-03-01 | Dowden Nathan J | Officer | A-Award | A | Stock Option (Right to Buy) | 50,100 | 13.73 | 687.9K | 50,100 | — | ↗ |
| 2024-03-01 | Doshi Dipal | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 158,500 | 13.73 | 2.18M | 158,500 | — | ↗ |
| 2024-02-15 | Doshi Dipal | Director / Officer | S-Sale | D | Common Stock | 1,000 | 15.00 | 15.0K | 243,279 | — | ↗ |
| 2024-01-16 | Doshi Dipal | Director / Officer | S-Sale | D | Common Stock | 1,000 | 15.99 | 16.0K | 244,279 | — | ↗ |
| 2023-12-26 | WENTWORTH KORY JAMES | Officer | S-Sale | D | Common Stock | 94 | 16.67 | 1.6K | 49,571 | — | ↗ |
| 2023-12-22 | WENTWORTH KORY JAMES | Officer | M-Exempt | D | Stock Option (Right to Buy) | 10,206 | 2.10 | 21.4K | 52,251 | — | ↗ |
| 2023-12-21 | WENTWORTH KORY JAMES | Officer | M-Exempt | A | Common Stock | 2,200 | 2.10 | 4.6K | 51,771 | — | ↗ |
| 2023-12-20 | Doshi Dipal | Director / Officer | S-Sale | D | Common Stock | 1,000 | 15.00 | 15.0K | 245,279 | — | ↗ |
| 2023-11-13 | Doshi Dipal | Director / Officer | S-Sale | D | Common Stock | 1,000 | 16.23 | 16.2K | 246,279 | — | ↗ |
| 2023-10-17 | Doshi Dipal | Director / Officer | S-Sale | D | Common Stock | 1,000 | 15.00 | 15.0K | 247,279 | — | ↗ |
| 2023-09-13 | Doshi Dipal | Director / Officer | S-Sale | D | Common Stock | 1,000 | 15.00 | 15.0K | 248,279 | — | ↗ |
| 2023-09-06 | WENTWORTH KORY JAMES | Officer | S-Sale | D | Common Stock | 46 | 14.03 | 645.38 | 49,571 | — | ↗ |
| 2023-09-06 | KREHER NERISSA | Officer | S-Sale | D | Common Stock | 21 | 14.00 | 294.00 | 40,037 | — | ↗ |
| 2023-09-06 | Dowden Nathan J | Officer | S-Sale | D | Common Stock | 59 | 14.01 | 826.41 | 48,168 | — | ↗ |
| 2023-09-05 | WENTWORTH KORY JAMES | Officer | F-InKind | D | Common Stock | 426 | 14.46 | 6.2K | 50,521 | — | ↗ |
| 2023-09-05 | Sethuraman Natarajan | Officer | F-InKind | D | Common Stock | 449 | 14.46 | 6.5K | 167,198 | — | ↗ |
| 2023-09-05 | KREHER NERISSA | Officer | F-InKind | D | Common Stock | 401 | 14.46 | 5.8K | 40,929 | — | ↗ |
| 2023-09-05 | Dowden Nathan J | Officer | F-InKind | D | Common Stock | 436 | 14.46 | 6.3K | 49,140 | — | ↗ |
| 2023-09-05 | Doshi Dipal | Director / Officer | F-InKind | D | Common Stock | 1,440 | 14.46 | 20.8K | 249,279 | — | ↗ |
| 2023-09-01 | WENTWORTH KORY JAMES | Officer | A-Award | A | Stock Option (Right to Buy) | 21,500 | 15.41 | 331.3K | 21,500 | — | ↗ |
| 2023-09-01 | Sethuraman Natarajan | Officer | A-Award | A | Stock Option (Right to Buy) | 21,500 | 15.41 | 331.3K | 21,500 | — | ↗ |
| 2023-09-01 | KREHER NERISSA | Officer | A-Award | A | Stock Option (Right to Buy) | 21,500 | 15.41 | 331.3K | 21,500 | — | ↗ |
| 2023-09-01 | Dowden Nathan J | Officer | A-Award | A | Common Stock | 14,200 | 0.00 | — | 49,576 | — | ↗ |
| 2023-09-01 | Doshi Dipal | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 75,250 | 15.41 | 1.16M | 75,250 | — | ↗ |
| 2023-09-01 | Chapman Gina | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2023-08-14 | Doshi Dipal | Director / Officer | S-Sale | D | Common Stock | 1,000 | 15.67 | 15.7K | 201,069 | — | ↗ |
| 2023-08-04 | KREHER NERISSA | Officer | S-Sale | D | Common Stock | 6,898 | 14.14 | 97.5K | 27,130 | — | ↗ |
| 2023-08-03 | KREHER NERISSA | Officer | M-Exempt | D | Stock Option (Right to Buy) | 9,464 | 2.10 | 19.9K | 94,910 | — | ↗ |
| 2023-08-02 | KREHER NERISSA | Officer | M-Exempt | A | Common Stock | 10,348 | 2.10 | 21.7K | 37,478 | — | ↗ |
| 2023-07-11 | WENTWORTH KORY JAMES | Officer | S-Sale | D | Common Stock | 3,884 | 18.00 | 69.9K | 36,747 | — | ↗ |
| 2023-07-11 | Sethuraman Natarajan | Officer | S-Sale | D | Common Stock | 14,852 | 18.04 | 267.9K | 153,447 | — | ↗ |
| 2023-07-11 | Dowden Nathan J | Officer | S-Sale | D | Common Stock | 3,897 | 18.05 | 70.3K | 35,376 | — | ↗ |
| 2023-07-10 | WENTWORTH KORY JAMES | Officer | M-Exempt | A | Common Stock | 6,116 | 2.10 | 12.8K | 42,863 | — | ↗ |
| 2023-07-10 | Sethuraman Natarajan | Officer | S-Sale | D | Common Stock | 3,026 | 18.00 | 54.5K | 168,299 | — | ↗ |
| 2023-07-10 | Dowden Nathan J | Officer | S-Sale | D | Common Stock | 3,200 | 18.00 | 57.6K | 39,273 | — | ↗ |
| 2023-06-29 | WENTWORTH KORY JAMES | Officer | M-Exempt | D | Stock Option (Right to Buy) | 8,790 | 2.10 | 18.5K | 74,657 | — | ↗ |
| 2023-06-22 | Dowden Nathan J | Officer | S-Sale | D | Common Stock | 7,097 | 16.02 | 113.7K | 42,473 | — | ↗ |
| 2023-06-21 | WENTWORTH KORY JAMES | Officer | S-Sale | D | Common Stock | 8,593 | 14.84 | 127.5K | 36,864 | — | ↗ |
| 2023-06-20 | Dowden Nathan J | Officer | S-Sale | D | Common Stock | 8,885 | 14.94 | 132.7K | 49,570 | — | ↗ |
| 2023-06-08 | Thistle Mary | Director | A-Award | A | Stock Option (Right to Buy) | 16,000 | 14.67 | 234.7K | 16,000 | — | ↗ |
| 2023-06-08 | PARMAR KUSH | Director / 10% Owner | A-Award | A | Stock Option (Right to Buy) | 16,000 | 14.67 | 234.7K | 16,000 | — | ↗ |
| 2023-06-08 | KIM PETER S | Director | A-Award | A | Stock Option (Right to Buy) | 16,000 | 14.67 | 234.7K | 16,000 | — | ↗ |
| 2023-06-08 | Crowley John F | Director | A-Award | A | Stock Option (Right to Buy) | 16,000 | 14.67 | 234.7K | 16,000 | — | ↗ |
| 2023-04-27 | Doshi Dipal | Director / Officer | S-Sale | D | Common Stock | 2,000 | 13.71 | 27.4K | 202,069 | — | ↗ |
| 2023-04-17 | Sethuraman Natarajan | Officer | S-Sale | D | Common Stock | 3,961 | 18.00 | 71.3K | 171,325 | — | ↗ |
| 2023-04-17 | Doshi Dipal | Director / Officer | S-Sale | D | Common Stock | 2,092 | 18.01 | 37.7K | 204,069 | — | ↗ |
| 2023-04-04 | Zeiher Bernhardt G | Director | A-Award | A | Stock Option (Right to Buy) | 32,000 | 14.43 | 461.8K | 32,000 | — | ↗ |
| 2023-03-27 | Doshi Dipal | Director / Officer | S-Sale | D | Common Stock | 1,800 | 14.63 | 26.3K | 256,011 | — | ↗ |
| 2023-03-02 | WENTWORTH KORY JAMES | Officer | S-Sale | D | Common Stock | 145 | 11.23 | 1.6K | 42,157 | — | ↗ |
| 2023-03-02 | Sethuraman Natarajan | Officer | F-InKind | D | Common Stock | 1,058 | 11.60 | 12.3K | 189,486 | — | ↗ |
| 2023-03-02 | KREHER NERISSA | Officer | F-InKind | D | Common Stock | 945 | 11.60 | 11.0K | 42,971 | — | ↗ |
| 2023-03-02 | Dowden Nathan J | Officer | F-InKind | D | Common Stock | 1,028 | 11.60 | 11.9K | 72,655 | — | ↗ |
| 2023-03-02 | Doshi Dipal | Director / Officer | F-InKind | D | Common Stock | 3,324 | 11.60 | 38.5K | 257,811 | — | ↗ |
| 2023-03-01 | WENTWORTH KORY JAMES | Officer | A-Award | A | Stock Option (Right to Buy) | 21,500 | 12.25 | 263.4K | 21,500 | — | ↗ |
| 2023-03-01 | Sethuraman Natarajan | Officer | A-Award | A | Stock Option (Right to Buy) | 21,500 | 12.25 | 263.4K | 21,500 | — | ↗ |
| 2023-03-01 | KREHER NERISSA | Officer | A-Award | A | Stock Option (Right to Buy) | 43,000 | 12.25 | 526.8K | 43,000 | — | ↗ |
| 2023-03-01 | Dowden Nathan J | Officer | A-Award | A | Stock Option (Right to Buy) | 43,000 | 12.25 | 526.8K | 43,000 | — | ↗ |
| 2023-03-01 | Doshi Dipal | Director / Officer | A-Award | A | Common Stock | 49,650 | 0.00 | — | 206,161 | — | ↗ |
| 2023-02-28 | Doshi Dipal | Director / Officer | S-Sale | D | Common Stock | 2,000 | 12.00 | 24.0K | 161,835 | — | ↗ |
| 2023-01-27 | Doshi Dipal | Officer | S-Sale | D | Common Stock | 2,000 | 12.00 | 24.0K | 163,835 | — | ↗ |
| 2023-01-09 | Doshi Dipal | Officer | S-Sale | D | Common Stock | 2,410 | 15.02 | 36.2K | 165,835 | — | ↗ |
| 2022-12-30 | KREHER NERISSA | Officer | S-Sale | D | Common Stock | 5,200 | 13.45 | 69.9K | 15,516 | — | ↗ |
| 2022-12-29 | Doshi Dipal | Officer | S-Sale | D | Common Stock | 400 | 15.01 | 6.0K | 168,245 | — | ↗ |
| 2022-12-28 | Doshi Dipal | Officer | S-Sale | D | Common Stock | 4,521 | 15.01 | 67.9K | 168,645 | — | ↗ |
| 2022-12-27 | Doshi Dipal | Officer | S-Sale | D | Common Stock | 600 | 14.80 | 8.9K | 182,235 | — | ↗ |
| 2022-12-08 | WENTWORTH KORY JAMES | Officer | M-Exempt | D | Stock Option (Right to Buy) | 4,550 | 0.00 | — | 100,947 | — | ↗ |
| 2022-12-05 | WENTWORTH KORY JAMES | Officer | M-Exempt | A | Common Stock | 200 | 2.10 | 420.00 | 16,709 | — | ↗ |
Executive team
Top executives
EBIT / Employee
-7.8K
Shares Outstanding
38.82M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2025 | Dipal Doshi Chief Executive Officer | 635.0K | — | 1.39M | 1.45M | 349.3K | 14.0K | 3.84M | 73.99% | ↗ |
| 2 | 2025 | Natarajan Sethuraman Ph. D. President of Research and Development | 520.0K | — | 726.0K | 760.4K | 234.0K | 14.0K | 2.25M | 65.93% | ↗ |
| 3 | 2025 | Nathan J. Dowden President and Chief Operating Officer | 499.2K | — | 726.0K | 760.4K | 224.6K | 13.3K | 2.22M | 66.85% | ↗ |
| 4 | 2024 | Dipal Doshi Chief Executive Officer | 610.0K | — | 1.44M | 1.49M | 335.5K | 13.8K | 3.89M | 75.35% | ↗ |
| 5 | 2024 | Dipal Doshi Chief Executive Officer | 610.0K | — | 1.44M | 1.49M | 335.5K | 13.8K | 3.89M | 75.35% | ↗ |
| 6 | 2024 | Nathan J. Dowden President and Chief Operating Officer | 480.0K | — | 1.28M | 472.6K | 216.0K | 13.8K | 2.46M | 71.15% | ↗ |
| 7 | 2024 | Nathan J. Dowden President and Chief Operating Officer | 480.0K | — | 1.28M | 472.6K | 216.0K | 13.8K | 2.46M | 71.15% | ↗ |
| 8 | 2024 | Natarajan Sethuraman Ph. D. President of Research and Development | 493.2K | — | 605.5K | 630.0K | 222.0K | 12.0K | 1.96M | 62.95% | ↗ |
| 9 | 2024 | Natarajan Sethuraman Ph. D. President of Research and Development | 493.2K | — | 605.5K | 630.0K | 222.0K | 12.0K | 1.96M | 62.95% | ↗ |
| 10 | 2023 | Dipal Doshi Chief Executive Officer | 585.0K | — | 1.37M | 1.39M | 370.0K | 13.2K | 3.74M | 74.08% | ↗ |
| 11 | 2023 | Natarajan Sethuraman Ph. D. President of Research and Development | 456.5K | — | 392.8K | 398.4K | 224.6K | 13.2K | 1.49M | 53.26% | ↗ |
| 12 | 2023 | Natarajan Sethuraman Ph. D. Chief Scientific Officer | 456.5K | — | 392.8K | 398.4K | 224.6K | 13.2K | 1.49M | 53.26% | ↗ |
| 13 | 2023 | Nathan J. Dowden President and Chief Operating Officer | 456.5K | — | 392.8K | 398.4K | 224.6K | 13.2K | 1.49M | 53.26% | ↗ |
| 14 | 2022 | Dipal Doshi Chief Executive Officer | 565.0K | — | 546.6K | 2.04M | 324.9K | 12.2K | 3.49M | 74.16% | ↗ |
| 15 | 2022 | Dipal Doshi President and Chief Executive Officer | 565.0K | — | 546.6K | 2.04M | 324.9K | 12.2K | 3.49M | 74.16% | ↗ |
| 16 | 2022 | Natarajan Sethuraman Ph. D. Chief Scientific Officer | 440.0K | — | 203.5K | 760.8K | 202.4K | 12.2K | 1.62M | 59.57% | ↗ |
| 17 | 2022 | Nathan J. Dowden Chief Operating Officer | 440.0K | — | 186.9K | 698.9K | 202.4K | 12.2K | 1.54M | 57.50% | ↗ |
| 18 | 2022 | Nathan J. Dowden President and Chief Operating Officer | 440.0K | — | 186.9K | 698.9K | 202.4K | 12.2K | 1.54M | 57.50% | ↗ |
| 19 | 2021 | Dipal Doshi President and Chief Executive Officer | 425.1K | 117.5K | — | 4.74M | 233.1K | 12.5K | 5.53M | 85.75% | ↗ |
| 20 | 2021 | Natarajan Sethuraman Ph. D. Chief Scientific Officer | 382.9K | 60.0K | — | 3.68M | 178.9K | — | 4.31M | 85.56% | ↗ |
| 21 | 2021 | Nathan J. Dowden Chief Operating Officer | 378.5K | 50.0K | — | 1.71M | 176.9K | — | 2.31M | 73.81% | ↗ |
| 22 | 2021 | Nathan Dowden Chief Operating Officer | 378.5K | 50.0K | — | 1.71M | 176.9K | — | 2.31M | 73.81% | ↗ |
| 23 | 2020 | Dipal Doshi President and Chief Executive Officer | 385.0K | — | — | 310.8K | 134.8K | 75.0K | 905.5K | 34.32% | ↗ |
| 24 | 2020 | Natarajan Sethuraman Ph. D. Chief Scientific Officer | 359.6K | — | — | 94.0K | 126.2K | — | 579.8K | 16.21% | ↗ |
| 25 | 2020 | Nathan Dowden Chief Operating Officer | 354.5K | — | — | 82.6K | 124.4K | — | 561.5K | 14.72% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Dipal Doshi | Chief Executive Officer & Director | 998.3K | male |
| Natarajan Sethuraman | President of Research & Development | 768.0K | — |
| Nathan J. Dowden | President & Chief Operating Officer | 737.2K | male |
| Kerry Robert | Senior Vice President of People | — | female |
| Kevin Healy | Senior Vice President of Regulatory Affairs | — | male |
| Kory James Wentworth | Chief Financial Officer & Treasurer | — | male |
| Sandeep Basnet | Head of Information Technology | — | — |
| Jared Cohen | General Counsel | — | — |
| Karla MacDonald | Chief Corporate Affairs Officer | — | female |
ESG Rating
ESG Score History BIOTECHNOLOGY
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for TRDA
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
